Number of Shares
37,673.00
Current Holdings Value*
$16.39 Mil
% of Portfolio
2.11%
Total Estimate Gain
$2.28 Mil
% of Total Estimate Gain
15.13%

T. Rowe Price Equity Income Portfolio's Elevance Health Inc Holding Summary

As of 2025-03-31, T. Rowe Price Equity Series, Inc. held 37,673.00 shares of Elevance Health Inc(ELV), totaling $16.39 Mil. This investment constitutes 2.11% of their stock portfolio, and T. Rowe Price Equity Series, Inc. now holds 0.02% of the outstanding Elevance Health Inc(ELV) stock.

The initial trade took place in 2019Q3. And since then T. Rowe Price Equity Income Portfolio has made 8 purchases of ELV, at an average price of $325.93, for a total of 46,229.00 shares. In addition, there have been 4 sales at an average price of $500.18 for 8,556.00 shares. Based on historical transaction data and ELV's current price of $346.88, T. Rowe Price Equity Income Portfolio's estimated gain on his ELV holdings is $2.28 Mil, reflecting a 15.13% gain to date.

T. Rowe Price Equity Income Portfolio ELV ($346.88) Holding Chart

T. Rowe Price Equity Income Portfolio ELV ($346.88) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1